{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":2536,"total_is_capped":false,"direct_labels_cover":6,"predictions_cover":2536,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"97bb0e201587","filters":{"topic":"Dermatology and Skin Diseases"}},"results":[{"id":"W2524051065","doi":"10.1056/nejmoa1610020","title":"Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis","year":2016,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2045,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Dupilumab; Atopic dermatitis; Placebo; Dermatology; Medicine; Alternative medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.04902998265317407,"gpt":0.3695702477616536,"spread":0.3205402651084795,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00153612,0.0001241767,0.001076126,0.0003135949,0.00001608165,0.000001824497,0.0001051293,0.0000577149,0.001200465],"category_scores_gemma":[0.005230174,0.00006341764,0.0001277044,0.000130414,0.0001571545,0.00009553029,0.00001245399,0.0001741255,0.000007437459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003911904,"about_ca_system_score_gemma":0.0002882385,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003510973,"about_ca_topic_score_gemma":0.00003476808,"domain_scores_codex":[0.9978754,0.0003148008,0.001193015,0.00009011704,0.0003567058,0.0001699931],"domain_scores_gemma":[0.9969891,0.001840545,0.0005946482,0.0001583422,0.0001375142,0.000279874],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.04263019,0.0008832414,0.1111664,0.0002907904,0.0008287466,0.006903856,0.001645218,0.000004717618,0.009356957,0.0007325611,0.1637173,0.66184],"study_design_scores_gemma":[0.9056329,0.002464895,0.0280321,0.002945997,0.0007311231,0.003716897,0.0002402104,0.00001011791,0.004957414,0.00145061,0.04969616,0.0001216044],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9692,0.005263539,0.0003842197,0.02100258,0.00116096,0.0001959427,0.000006856677,0.000008086157,0.002777787],"genre_scores_gemma":[0.9966596,0.0009459053,0.0001916681,0.0003764866,0.001556568,0.000001375861,0.000003098722,0.000008884042,0.0002564575],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8630027,"threshold_uncertainty_score":0.9997126,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162201817","doi":"10.1172/jci21060","title":"New insights into atopic dermatitis","year":2004,"lang":"en","type":"review","venue":"Journal of Clinical Investigation","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1407,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Christie (Canada)","funders":"","keywords":"Atopic dermatitis; Medicine; Immunology; Asthma; Dermatology; Disease; Phenotype; Atopy; Biology; Pathology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.1214837057909964,"gpt":0.4382144312739039,"spread":0.3167307254829075,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004187688,0.0002388604,0.002498044,0.0002426219,0.0000456697,0.00002348871,0.0001909799,0.0006960799,0.0001018898],"category_scores_gemma":[0.002747718,0.0001625185,0.001189927,0.0002360938,0.0002013649,0.0002009185,0.000031053,0.001115531,0.0001492245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008766286,"about_ca_system_score_gemma":0.00495945,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006349771,"about_ca_topic_score_gemma":0.000002721522,"domain_scores_codex":[0.9958794,0.0003805429,0.003074314,0.0001745764,0.0003655386,0.0001256221],"domain_scores_gemma":[0.9958231,0.0006756302,0.002286588,0.00024918,0.0002271684,0.0007383762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001065574,0.0001000897,0.001436461,0.01290782,0.0004750958,0.0006294331,0.00008784176,6.816889e-7,5.501527e-8,0.0004869115,0.04819625,0.9356687],"study_design_scores_gemma":[0.001059669,0.0001644871,0.003377589,0.04107774,0.00255241,0.001282902,0.000004473467,0.000001535186,0.000002672013,0.01982949,0.9305097,0.0001372828],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004269294,0.996413,0.0002774165,0.001023017,0.001239204,0.0002455783,7.363483e-7,0.00001663658,0.0003575135],"genre_scores_gemma":[0.0003296886,0.991941,0.004571064,0.0012545,0.001580637,0.000002619571,0.00003603095,0.00002455602,0.0002598513],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9355314,"threshold_uncertainty_score":0.8797851,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117983771","doi":"10.1016/j.jaad.2013.10.010","title":"Guidelines of care for the management of atopic dermatitis","year":2013,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1257,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Atopic dermatitis; Guideline; Disease; Dermatology; Disease management; Intensive care medicine; MEDLINE; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.05813627628411073,"gpt":0.405380081157618,"spread":0.3472438048735073,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001505909,0.0002889395,0.003569495,0.0002410693,0.00005709771,0.000002829532,0.00100924,0.0002156096,0.00002788072],"category_scores_gemma":[0.0001662124,0.0001429837,0.001570986,0.0003256782,0.001088051,0.00004715379,0.0001843368,0.0004883723,0.000002966761],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003263782,"about_ca_system_score_gemma":0.0002281027,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000683784,"about_ca_topic_score_gemma":3.537727e-7,"domain_scores_codex":[0.9966545,0.0002792017,0.002350072,0.0001398471,0.0003397457,0.0002366506],"domain_scores_gemma":[0.9923914,0.0006887799,0.006112966,0.0003494601,0.0003763733,0.0000809899],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008660321,0.0001358355,0.001872747,0.09156302,0.006098075,0.00005710476,0.0001652552,0.00000508325,0.000003034218,0.0008031113,0.1120935,0.7871166],"study_design_scores_gemma":[0.0007124774,0.00008356725,0.002014846,0.01321785,0.008892956,0.008493573,0.0006408082,0.000006921309,0.0001454091,0.0002400003,0.9654229,0.0001286446],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008481954,0.9898725,0.00009336306,0.007761664,0.0002303256,0.0009815078,0.00005407311,0.000004184578,0.0001542328],"genre_scores_gemma":[0.006715654,0.989834,0.002323581,0.000883804,0.00008779968,0.00004031613,0.000004094057,0.00002933831,0.00008144251],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8533295,"threshold_uncertainty_score":0.5830705,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2610814011","doi":"10.1016/s0140-6736(17)31191-1","title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1243,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; University of British Columbia; Queen's University","funders":"British Association of Dermatologists","keywords":"Dupilumab; Eczema Area and Severity Index; Atopic dermatitis; Medicine; Placebo; Concomitant; Clinical endpoint; Dermatology; Dermatology Life Quality Index; Internal medicine; Randomized controlled trial; Placebo-controlled study; Disease; Double blind; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03563158057817713,"gpt":0.3192870028795328,"spread":0.2836554223013557,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002002381,0.0001977482,0.001052544,0.00003774752,0.0002350258,0.00008803347,0.0002898011,0.00008223693,0.0001324967],"category_scores_gemma":[0.00004451436,0.0001145281,0.0001021713,0.00003103654,0.0002659544,0.0001026666,0.0001162294,0.0001682449,0.00001701553],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002378516,"about_ca_system_score_gemma":0.00006257113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001122915,"about_ca_topic_score_gemma":0.00003544087,"domain_scores_codex":[0.9987598,0.0000931313,0.0003783733,0.0002505122,0.0002231088,0.0002950617],"domain_scores_gemma":[0.9985623,0.0001291006,0.0002152244,0.0008776794,0.00005517497,0.0001604982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9726701,0.0003768918,0.01853561,0.0003313657,0.0007843052,0.0004889757,0.0001872794,0.000003509891,0.00001293112,0.0003025814,0.002724624,0.003581775],"study_design_scores_gemma":[0.9159288,0.000530612,0.08137577,0.0003331566,0.0006907163,0.0001998996,0.00004064031,0.0001723093,0.000193049,0.0001022889,0.0002844832,0.0001482398],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863313,0.0006215969,0.000259709,0.004417632,0.0001684596,0.003324805,0.0000211957,0.00003328233,0.004822054],"genre_scores_gemma":[0.997506,0.0002437758,0.0001917033,0.0007372821,0.0001865993,0.0003157217,0.00001279121,0.00001553373,0.0007906115],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06284016,"threshold_uncertainty_score":0.467032,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2142327072","doi":"10.1016/j.jaad.2014.03.023","title":"Guidelines of care for the management of atopic dermatitis","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1208,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Atopic dermatitis; Dermatology; MEDLINE","retraction":null,"screen_n_in":null,"score":{"opus":0.02141403959256145,"gpt":0.3423750589506289,"spread":0.3209610193580674,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001493889,0.0001082869,0.0008125282,0.0001037991,0.0000501781,0.000001363856,0.0004711319,0.00006428734,0.00001102875],"category_scores_gemma":[0.0001807703,0.00005891167,0.0003859496,0.0001709547,0.0007742774,0.00003647463,0.00008330278,0.0001816063,7.783046e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001110453,"about_ca_system_score_gemma":0.00004837269,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005485256,"about_ca_topic_score_gemma":7.088275e-7,"domain_scores_codex":[0.9984379,0.0001364067,0.0009636926,0.00007610086,0.000232132,0.0001537675],"domain_scores_gemma":[0.9973001,0.0003967572,0.001797724,0.0001977962,0.000254985,0.00005259131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001573817,0.0004975954,0.6474422,0.008928242,0.005717746,0.00007290005,0.001742128,0.0003567903,0.002226319,0.01527838,0.2198964,0.09626756],"study_design_scores_gemma":[0.004423513,0.0003752035,0.8020032,0.001332992,0.003265696,0.007950579,0.004399115,0.0005300123,0.04841658,0.003899174,0.123209,0.000194959],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9133167,0.009071535,0.001768423,0.07455054,0.0002475875,0.0004173539,0.00001883509,0.000006391135,0.0006026078],"genre_scores_gemma":[0.9926705,0.0009936785,0.003360661,0.002870355,0.00005375445,0.000005439091,6.669485e-7,0.000009773768,0.00003522123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.154561,"threshold_uncertainty_score":0.2852857,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2140192959","doi":"10.1056/nejmra1011040","title":"Filaggrin Mutations Associated with Skin and Allergic Diseases","year":2011,"lang":"en","type":"review","venue":"New England Journal of Medicine","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1204,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Trinity College","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Filaggrin; Mutation; Genetics; Biology; Atopic dermatitis; Medicine; Gene; Immunology; Dermatology","retraction":null,"screen_n_in":null,"score":{"opus":0.03651821391203088,"gpt":0.3139212704983854,"spread":0.2774030565863546,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003478373,0.0003328006,0.002237529,0.0003815811,0.0000592439,0.000007463123,0.000126985,0.0001605724,0.0005323665],"category_scores_gemma":[0.001057048,0.0001726377,0.0002068684,0.0002277749,0.0003006554,0.00006863793,0.00002052571,0.000572476,0.000006214817],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003923069,"about_ca_system_score_gemma":0.000749161,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001103397,"about_ca_topic_score_gemma":0.00001626495,"domain_scores_codex":[0.9982251,0.0002823313,0.0007768631,0.0001787617,0.0003286567,0.0002083012],"domain_scores_gemma":[0.9973756,0.0007108765,0.0008794018,0.0001814775,0.0001995821,0.0006530445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002708697,0.0002044491,0.001312013,0.002655961,0.001673547,0.003755145,0.0002670853,2.583783e-7,5.794893e-8,0.0000473498,0.03635637,0.9534569],"study_design_scores_gemma":[0.02020383,0.0009227439,0.003703348,0.03999814,0.0116317,0.01616952,0.0000481382,8.640474e-7,1.396036e-7,0.0002566822,0.9068844,0.0001805151],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003822545,0.9972623,0.00002735152,0.0005123849,0.000240875,0.0002627129,0.00002175731,0.00001763591,0.001272754],"genre_scores_gemma":[0.002044971,0.9952955,0.00006678085,0.0001799906,0.001289057,0.000004994051,0.0001429946,0.00003713461,0.000938608],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9532764,"threshold_uncertainty_score":0.7039961,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135790224","doi":"10.1084/jem.20051135","title":"TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand","year":2005,"lang":"en","type":"article","venue":"The Journal of Experimental Medicine","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1102,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Thymic stromal lymphopoietin; Tumor necrosis factor alpha; Immunology; Cell biology; T cell; Dendritic cell; Stromal cell; Interleukin 12; Inflammation; Biology; Cancer research; Cytotoxic T cell; Immune system; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.02486514378919737,"gpt":0.322254385576053,"spread":0.2973892417868557,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006341616,0.000211506,0.0004566323,0.0001245683,0.0001297001,0.00000748765,0.000233388,0.00009946058,0.0006865867],"category_scores_gemma":[0.00016633,0.0001244547,0.00007423045,0.0001735917,0.0004099674,0.0003228451,0.00003997192,0.0004372675,0.00006726139],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001061707,"about_ca_system_score_gemma":0.0001855491,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000821486,"about_ca_topic_score_gemma":8.365377e-7,"domain_scores_codex":[0.998204,0.0003745927,0.0005846294,0.0001272082,0.000447919,0.0002616292],"domain_scores_gemma":[0.9986244,0.0003024623,0.0002812834,0.000330376,0.0001722347,0.000289191],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.009695081,0.0005618799,0.0004239135,0.00001925795,0.00007824438,0.0004467348,0.006345751,0.000007280183,0.9662411,0.00000797846,0.01609623,0.00007651421],"study_design_scores_gemma":[0.004073934,0.001974782,0.002760431,0.0002934874,0.0002155762,0.002996659,0.007192025,0.00001372345,0.9715889,0.00002573835,0.008740024,0.0001246876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9815893,0.01274162,0.000007328094,0.003389285,0.0005650294,0.0001980655,0.000001229794,0.00002353083,0.001484675],"genre_scores_gemma":[0.9947971,0.0002904948,0.0001958242,0.003368972,0.0007854443,0.000002251237,0.000003177382,0.00003050174,0.0005263082],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0132078,"threshold_uncertainty_score":0.7517642,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2784010902","doi":"10.1111/all.13401","title":"Epidemiology of atopic dermatitis in adults: Results from an international survey","year":2018,"lang":"en","type":"article","venue":"Allergy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":875,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Atopic dermatitis; Epidemiology; Medicine; Dermatology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03564128873015198,"gpt":0.3317375868962258,"spread":0.2960962981660738,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002123898,0.0000622517,0.0002335565,0.00006828459,0.00001260012,5.440177e-7,0.0001157979,0.00009642552,0.0003488229],"category_scores_gemma":[0.00168268,0.00005598386,0.00002978794,0.00005787879,0.0001507871,0.00006787374,0.00002989483,0.00006260887,0.00003957974],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001194805,"about_ca_system_score_gemma":0.00004022829,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004030173,"about_ca_topic_score_gemma":0.007685438,"domain_scores_codex":[0.9990299,0.0002426339,0.0003736341,0.0001758772,0.00006019699,0.0001177689],"domain_scores_gemma":[0.9990131,0.0004970353,0.00009217813,0.000234527,0.00009879949,0.0000643698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004627155,0.0001290081,0.9909964,0.000005170613,0.00006717101,0.00003588838,0.0002668994,0.000001235601,0.000003404351,0.0002897118,0.006786287,0.0009561448],"study_design_scores_gemma":[0.00198912,0.00006746445,0.9930071,0.00008740885,0.00000377936,0.00001468639,0.00002747823,0.0004448909,0.0001201677,0.0008329714,0.003358776,0.00004611092],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933997,0.0002570596,0.00003053537,0.001293084,0.00030671,0.00005347328,0.000175429,0.0000153073,0.004468686],"genre_scores_gemma":[0.9964266,0.000128552,0.0003583288,0.001856,0.0001246121,0.000004136757,0.001016575,0.000005004139,0.00008013036],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004388556,"threshold_uncertainty_score":0.6092443,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W189068515","doi":"10.1016/j.jaad.2014.03.030","title":"Guidelines of care for the management of atopic dermatitis","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":871,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute for Health and Care Research","keywords":"Medicine; Atopic dermatitis; Guideline; Dermatology; Intensive care medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02141403959256145,"gpt":0.3423750589506289,"spread":0.3209610193580674,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001493889,0.0001082869,0.0008125282,0.0001037991,0.0000501781,0.000001363856,0.0004711319,0.00006428734,0.00001102875],"category_scores_gemma":[0.0001807703,0.00005891167,0.0003859496,0.0001709547,0.0007742774,0.00003647463,0.00008330278,0.0001816063,7.783046e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001110453,"about_ca_system_score_gemma":0.00004837269,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005485256,"about_ca_topic_score_gemma":7.088275e-7,"domain_scores_codex":[0.9984379,0.0001364067,0.0009636926,0.00007610086,0.000232132,0.0001537675],"domain_scores_gemma":[0.9973001,0.0003967572,0.001797724,0.0001977962,0.000254985,0.00005259131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001573817,0.0004975954,0.6474422,0.008928242,0.005717746,0.00007290005,0.001742128,0.0003567903,0.002226319,0.01527838,0.2198964,0.09626756],"study_design_scores_gemma":[0.004423513,0.0003752035,0.8020032,0.001332992,0.003265696,0.007950579,0.004399115,0.0005300123,0.04841658,0.003899174,0.123209,0.000194959],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9133167,0.009071535,0.001768423,0.07455054,0.0002475875,0.0004173539,0.00001883509,0.000006391135,0.0006026078],"genre_scores_gemma":[0.9926705,0.0009936785,0.003360661,0.002870355,0.00005375445,0.000005439091,6.669485e-7,0.000009773768,0.00003522123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.154561,"threshold_uncertainty_score":0.2852857,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162803006","doi":"10.1084/jem.20062211","title":"Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells","year":2007,"lang":"en","type":"article","venue":"The Journal of Experimental Medicine","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":783,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Thymic stromal lymphopoietin; Immunology; Immune system; Cytokine; Inflammation; Allergic inflammation; Tumor necrosis factor alpha; Stromal cell; Biology; Mast cell; Interleukin 33; Interleukin; Cancer research","retraction":null,"screen_n_in":null,"score":{"opus":0.01150444937292098,"gpt":0.2929146175052334,"spread":0.2814101681323124,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00115287,0.0001974929,0.0004316785,0.0002739129,0.0001024601,0.000007960505,0.0001541069,0.00008129204,0.0003788254],"category_scores_gemma":[0.00009914786,0.0001156015,0.00005483439,0.0001695663,0.0002552939,0.00009961041,0.00003696751,0.0002375569,0.00001067481],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001406356,"about_ca_system_score_gemma":0.00006269374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007258104,"about_ca_topic_score_gemma":0.000006631275,"domain_scores_codex":[0.9983179,0.0002236756,0.0006962809,0.0001385967,0.0003470796,0.0002764656],"domain_scores_gemma":[0.9988462,0.0003641545,0.0002746328,0.0001722043,0.00005860194,0.0002842075],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.03045289,0.0002632693,0.0007867676,0.00002065337,0.00004884368,0.000399056,0.004444371,9.794052e-7,0.9495615,0.000001484321,0.01350739,0.0005128245],"study_design_scores_gemma":[0.007474037,0.002093167,0.01584529,0.0004065365,0.00009187149,0.001100816,0.00793526,0.000004477321,0.9634112,0.00001328467,0.001515551,0.0001085213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932223,0.002002893,0.00003170054,0.004069985,0.0001821367,0.0003298566,0.00001216962,0.00000910797,0.0001398741],"genre_scores_gemma":[0.9979,0.00008472053,0.0001526051,0.00121433,0.0002291071,0.00000222673,0.000004918467,0.00002082243,0.0003912428],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02297886,"threshold_uncertainty_score":0.4714094,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2055172715","doi":"10.1056/nejmoa1402895","title":"Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":780,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Université Laval; University of Saskatchewan; Institut universitaire de cardiologie et de pneumologie de Québec; McMaster University; Montreal Heart Institute","funders":"Amgen","keywords":"Medicine; Thymic stromal lymphopoietin; Exhaled nitric oxide; Immunology; Allergen; Placebo; Asthma; Bronchoconstriction; Sputum; Allergic inflammation; Allergy; Pharmacology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01299558239773334,"gpt":0.3124587297122323,"spread":0.2994631473144989,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009153785,0.0001683677,0.0008300428,0.0003434609,0.00003968004,0.00000332485,0.0001422159,0.00008179692,0.0001242658],"category_scores_gemma":[0.00315859,0.0001026966,0.0000993827,0.0001405769,0.0001075685,0.00007941452,0.00001160278,0.0003058844,0.000008518981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000123137,"about_ca_system_score_gemma":0.0001527172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001327008,"about_ca_topic_score_gemma":0.000002176568,"domain_scores_codex":[0.9981629,0.0004192196,0.0005976652,0.0001259075,0.0005062122,0.0001880771],"domain_scores_gemma":[0.9976351,0.001108831,0.0004005072,0.0002387188,0.0001759099,0.000440981],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.02491119,0.002635211,0.08102445,0.002081332,0.001201397,0.00800832,0.003258971,0.00004719397,0.6295407,0.0006486899,0.03765324,0.2089894],"study_design_scores_gemma":[0.1137709,0.01690064,0.7751786,0.004657257,0.00101693,0.008205321,0.0001789403,0.0002631877,0.06302967,0.001213697,0.01533504,0.0002498232],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934387,0.001080842,0.000217897,0.003508689,0.000657337,0.0001466571,6.15501e-7,0.00001449342,0.0009347817],"genre_scores_gemma":[0.9966715,0.0002065329,0.0002319123,0.001036526,0.001676848,6.015359e-7,0.000005599873,0.0000173301,0.0001531417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6941541,"threshold_uncertainty_score":0.4187844,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2155912911","doi":"10.1111/j.1398-9995.2006.01153.x","title":"Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report","year":2006,"lang":"en","type":"review","venue":"Allergy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":738,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; McGill University","funders":"","keywords":"Medicine; Atopic dermatitis; Allergy; Clinical immunology; Guideline; Asthma; Task force; Immunology; Consensus conference; Atopy; Family medicine; Pediatrics; Pathology; Internal medicine; Political science","retraction":null,"screen_n_in":null,"score":{"opus":0.02829199182175652,"gpt":0.3440593658091485,"spread":0.315767373987392,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0002817717,0.0005417806,0.003600752,0.0003752885,0.00004199505,0.000004548152,0.0001426177,0.0007727603,0.00001909949],"category_scores_gemma":[0.0002559121,0.0004520277,0.0002556622,0.000168778,0.003120272,0.00004305636,0.0002583935,0.0005141028,0.000001045308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002789803,"about_ca_system_score_gemma":0.0001149936,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000550857,"about_ca_topic_score_gemma":0.0001054418,"domain_scores_codex":[0.9955705,0.0009731195,0.002200915,0.000775488,0.0001227731,0.0003572177],"domain_scores_gemma":[0.9967741,0.001049641,0.001706668,0.0002771898,0.00004254736,0.0001498528],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.000270757,0.001107757,0.2032589,0.001647905,0.009002628,0.000631193,0.0001510605,1.233247e-7,0.000002572348,0.000210206,0.001126165,0.7825907],"study_design_scores_gemma":[0.00295999,0.0005700269,0.7744429,0.002184085,0.0005660651,0.007505962,0.00003758161,0.000001245705,0.000006118268,0.00002971603,0.2114483,0.000248079],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.4159267,0.5829033,1.517929e-7,0.0004251542,0.00002267473,0.0004858261,0.00007677312,0.0000126028,0.0001467767],"genre_scores_gemma":[0.08956203,0.9097539,0.0001793191,0.0001157331,0.00004419617,0.0000545271,0.000199055,0.00004541401,0.00004581922],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7823426,"threshold_uncertainty_score":0.9997932,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2121580723","doi":"10.4049/jimmunol.171.6.3262","title":"Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes","year":2003,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":730,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Christie (Canada)","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute","keywords":"Psoriasis; Immunology; Proinflammatory cytokine; Innate immune system; Atopic dermatitis; Immune system; Antimicrobial peptides; Cytokine; Tumor necrosis factor alpha; Beta defensin; Medicine; Biology; Inflammation; Antimicrobial; Microbiology","retraction":null,"screen_n_in":null,"score":{"opus":0.01420217284664528,"gpt":0.2794202155234036,"spread":0.2652180426767584,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007519,0.0001137793,0.0005563595,0.0002612769,0.00005099113,0.000001745925,0.0002100855,0.0001124742,0.0001476305],"category_scores_gemma":[0.0006702058,0.00007943987,0.0001261457,0.0002226295,0.0002165481,0.00006493046,0.00004021847,0.0002305244,0.0000131323],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000329561,"about_ca_system_score_gemma":0.0002070053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002865456,"about_ca_topic_score_gemma":0.000002241604,"domain_scores_codex":[0.9978291,0.000979361,0.0007931209,0.00006610366,0.0001704766,0.0001618014],"domain_scores_gemma":[0.9985263,0.0002519656,0.0005885591,0.0003086296,0.0002738462,0.00005065708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01833064,0.001293157,0.02069456,0.0001944238,0.002210476,0.0001670132,0.004179632,0.0001296316,0.9404796,0.0004895672,0.004229221,0.00760203],"study_design_scores_gemma":[0.00275765,0.0006003341,0.5136642,0.000201344,0.0002624403,0.004611102,0.0008098205,0.00000144057,0.471692,0.0005976259,0.004737111,0.00006486545],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827275,0.01504619,0.0000659174,0.001356027,0.000447624,0.0001807021,0.00000478285,0.000004954161,0.0001663268],"genre_scores_gemma":[0.9980689,0.001233723,0.0003046267,0.0001955549,0.00002786825,0.000002505222,0.000002265596,0.000009843309,0.0001547368],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4929697,"threshold_uncertainty_score":0.3239464,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2892288216","doi":"10.1016/j.jaci.2018.08.022","title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","year":2018,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":678,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Innovaderm (Canada)","funders":"Janssen Biotech; Allergan; LEO Pharma; Eli Lilly and Company; Galderma; Dermira; Celgene; Regeneron Pharmaceuticals; Novartis; Maruho; Amgen; Pfizer; AbbVie; Sanofi; Merck","keywords":"Dupilumab; Atopic dermatitis; SCORAD; Filaggrin; Eczema Area and Severity Index; Medicine; Placebo; Loricrin; Internal medicine; Immunology; Pathology; Psoriasis; Dermatology Life Quality Index; Biology; Keratinocyte; Involucrin","retraction":null,"screen_n_in":null,"score":{"opus":0.008808492719377024,"gpt":0.2738651296625087,"spread":0.2650566369431317,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001174038,0.0001030193,0.0004680678,0.00008801869,0.00005499559,0.00001076358,0.00006487314,0.0001820641,0.00002931854],"category_scores_gemma":[0.0001854418,0.00006870118,0.00004969842,0.00004379321,0.0007861219,0.0001097898,0.00004135807,0.0002997422,0.000003277599],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001183799,"about_ca_system_score_gemma":0.00009406285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006154397,"about_ca_topic_score_gemma":0.00002534172,"domain_scores_codex":[0.9988531,0.0001379613,0.0006374768,0.0001157092,0.0000893515,0.0001663648],"domain_scores_gemma":[0.9990765,0.0001930587,0.0003290186,0.00009772674,0.0002161763,0.00008756368],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001697064,0.0003882493,0.9851759,0.00005024426,0.0009520046,0.0006159412,0.0002290658,6.062674e-8,0.000007898186,0.0001479414,0.0002938299,0.01044177],"study_design_scores_gemma":[0.005002865,0.003091302,0.9845961,0.0003509149,0.00008766885,0.005553049,0.0002489385,0.000006037828,0.00001921128,0.0001932163,0.0007770761,0.00007366561],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945462,0.004374399,0.000005186247,0.0005294587,0.0002272572,0.0001019074,0.000001351985,0.00000663772,0.000207645],"genre_scores_gemma":[0.9973966,0.001870788,0.0001302469,0.0004253472,0.00008394244,0.000001866405,0.000001878503,0.000006816689,0.00008253041],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01036811,"threshold_uncertainty_score":0.2896499,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2130281254","doi":"10.1093/ndt/gfl461","title":"Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","year":2006,"lang":"en","type":"article","venue":"Nephrology Dialysis Transplantation","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":630,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Humber River Regional Hospital","funders":"","keywords":"Medicine; Dialysis; Depression (economics); Internal medicine; Quality of life (healthcare); Hemodialysis; Odds ratio; End stage renal disease; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.01158747980856339,"gpt":0.277540936120231,"spread":0.2659534563116676,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004873806,0.0002183546,0.0004984837,0.0002773182,0.0001235717,0.00004214688,0.0001548216,0.0001627852,0.00006165255],"category_scores_gemma":[0.0006036781,0.0001610664,0.0001454698,0.000283628,0.0001220376,0.000292506,0.00002248851,0.0002145963,0.00001850466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000412716,"about_ca_system_score_gemma":0.00003505826,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004317863,"about_ca_topic_score_gemma":0.008035096,"domain_scores_codex":[0.9974164,0.0007144613,0.0007706144,0.0005059976,0.0003663798,0.0002261588],"domain_scores_gemma":[0.9966569,0.002545673,0.0002585078,0.0003338072,0.000148142,0.00005696546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003378795,0.001649001,0.9886391,0.000007784752,0.0007982813,0.0002253412,0.00300505,0.0001174816,0.0000455668,0.00001479831,0.0004916515,0.001627193],"study_design_scores_gemma":[0.01007087,0.00007121212,0.9848087,0.00001395046,0.003412322,0.00002006183,0.0006045609,0.0001661239,0.00003201502,0.0001431931,0.0005193762,0.0001375783],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901953,0.0001025575,0.0002754401,0.007552942,0.0001731637,0.0005582266,0.0003929889,0.00004831768,0.0007010314],"genre_scores_gemma":[0.9933888,0.0003617188,0.0001617731,0.002533145,0.000136582,0.000100751,0.00326713,0.00001451626,0.00003562421],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006692073,"threshold_uncertainty_score":0.6568097,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3091046625","doi":"10.1111/bjd.19574","title":"Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":595,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Université Laval; Probity Medical Research; Lynde Centre for Dermatology; University of Toronto","funders":"LEO Pharma","keywords":"Placebo; Atopic dermatitis; Double blind; Medicine; Randomized controlled trial; Physical therapy; Dermatology; Internal medicine; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04667870606626964,"gpt":0.3308195138942538,"spread":0.2841408078279842,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009143237,0.0004330803,0.005122462,0.0002441644,0.0002431055,0.000167302,0.00029224,0.0003680238,0.0001647123],"category_scores_gemma":[0.006047627,0.000404786,0.001001292,0.0001680816,0.0002795219,0.0003713375,0.00005838529,0.0006024631,0.00001946343],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003608518,"about_ca_system_score_gemma":0.0003513701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007917362,"about_ca_topic_score_gemma":0.00006624615,"domain_scores_codex":[0.9936933,0.00126287,0.003525812,0.0005274112,0.0003750277,0.0006155637],"domain_scores_gemma":[0.9924256,0.004403858,0.001430087,0.0002266522,0.0004981288,0.001015647],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9381767,0.0006087595,0.0001788622,0.000166364,0.002436885,0.009440915,0.001290959,0.00008130003,0.0001030663,0.00009562218,0.04135537,0.006065228],"study_design_scores_gemma":[0.9422907,0.0002185299,0.0001270952,0.00053769,0.00295583,0.04370669,0.0004077881,0.004677908,0.001419254,0.0007266107,0.002570315,0.0003616303],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9335757,0.01913999,0.008231684,0.03127382,0.0007431795,0.00577543,0.0006400807,0.0000859932,0.0005341046],"genre_scores_gemma":[0.988566,0.001503987,0.003205454,0.005626228,0.0006201754,0.0001672835,0.0001790837,0.00005060016,0.00008119091],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05499027,"threshold_uncertainty_score":0.9998404,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2076977862","doi":"10.2340/00015555-1246","title":"Assessment of Pruritus Intensity: Prospective Study on Validity and Reliability of the Visual Analogue Scale, Numerical Rating Scale and Verbal Rating Scale in 471 Patients with Chronic Pruritus","year":2012,"lang":"en","type":"article","venue":"Acta Dermato Venereologica","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":571,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Health Services and Policy Research","funders":"","keywords":"Visual analogue scale; Rating scale; Reliability (semiconductor); Scale (ratio); Concurrent validity; Audiology; Psychology; Correlation; Physical therapy; Intensity (physics); Validity; Medicine; Clinical psychology; Psychometrics; Developmental psychology; Mathematics; Cartography","retraction":null,"screen_n_in":null,"score":{"opus":0.01175373585162947,"gpt":0.2862808845047754,"spread":0.2745271486531459,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004319757,0.0002347228,0.0006995221,0.00007104225,0.0001527335,0.00001039547,0.0001061279,0.0001319286,0.000008824577],"category_scores_gemma":[0.0003078132,0.0001441352,0.00006208997,0.0002645457,0.0005404356,0.0001640236,0.0002416329,0.0003714253,4.045912e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001106639,"about_ca_system_score_gemma":0.0001201732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005932414,"about_ca_topic_score_gemma":0.00004894322,"domain_scores_codex":[0.9979043,0.0004524843,0.0005498171,0.0003786046,0.0003657187,0.000349056],"domain_scores_gemma":[0.9987569,0.0002595554,0.0003323262,0.0003432139,0.000167606,0.0001403446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003349259,0.003250948,0.9949037,0.0001820171,0.00003630055,0.000007849693,0.0009016672,0.000007515931,0.0002091608,0.000006266723,0.00005193322,0.0001076748],"study_design_scores_gemma":[0.00262899,0.0008265899,0.9925487,0.000194002,0.000156654,0.00005459839,0.000827219,0.0003888597,0.002179222,0.00004306407,0.00000771668,0.0001443709],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980092,0.0001176493,0.00002270294,0.0001902882,0.00007061354,0.001278043,0.00001414959,0.00002352556,0.0002738304],"genre_scores_gemma":[0.9994784,0.00001333981,0.0002716332,0.0001128665,0.0000293238,0.00006390133,0.00001409268,0.00001226187,0.000004166568],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002424358,"threshold_uncertainty_score":0.5877661,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2174132185","doi":"10.1016/s0140-6736(15)00388-8","title":"Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial","year":2015,"lang":"en","type":"article","venue":"The Lancet","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":566,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Eczema Area and Severity Index; Dupilumab; Medicine; Atopic dermatitis; Blinding; Placebo; Dermatology Life Quality Index; Randomized controlled trial; Clinical trial; Internal medicine; Adverse effect; SCORAD; Placebo-controlled study; Clinical endpoint; Dermatology; Double blind; Disease; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01984300005220019,"gpt":0.2878115342263952,"spread":0.267968534174195,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003313577,0.0001963316,0.00156848,0.00006923603,0.00006115158,0.00001781243,0.0001119878,0.00008733417,0.00003322065],"category_scores_gemma":[0.0005164794,0.0001091104,0.00008359746,0.0001083587,0.000102418,0.00006733323,0.00002496963,0.0001524402,0.000007092225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004403618,"about_ca_system_score_gemma":0.0001188398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005128116,"about_ca_topic_score_gemma":0.00003294049,"domain_scores_codex":[0.9984999,0.0003290945,0.0004656286,0.0002090423,0.0002070366,0.000289354],"domain_scores_gemma":[0.9987445,0.0006001552,0.0001283017,0.0002945614,0.00005660777,0.0001759133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9903394,0.0006633583,0.001674381,0.00006003694,0.0003789311,0.0001243014,0.001029903,0.00004050113,0.000009289988,0.00007044311,0.003837703,0.001771761],"study_design_scores_gemma":[0.9937927,0.001140699,0.001988376,0.0002893549,0.0003659398,0.00009315107,0.0001834457,0.001548745,0.00005927193,0.0001009648,0.0003169813,0.0001203317],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875292,0.001352655,0.0001172689,0.004141821,0.00006703338,0.004699625,0.00003431273,0.00003334341,0.002024711],"genre_scores_gemma":[0.9980498,0.00010283,0.0001010341,0.0008801032,0.0001337146,0.0004271286,0.00003417696,0.00001286321,0.0002583617],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01052056,"threshold_uncertainty_score":0.4449393,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3164705475","doi":"10.1016/s0140-6736(21)00588-2","title":"Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":543,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"AbbVie","keywords":"Eczema Area and Severity Index; Atopic dermatitis; Medicine; Placebo; Internal medicine; Randomized controlled trial; Clinical trial; Clinical endpoint; Dermatology","retraction":null,"screen_n_in":null,"score":{"opus":0.07452446434539767,"gpt":0.3370647134656402,"spread":0.2625402491202425,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001097127,0.000308073,0.001878884,0.00006970335,0.0001515534,0.0000895344,0.0001579068,0.000150216,0.00003410721],"category_scores_gemma":[0.002059548,0.0001953256,0.0001068414,0.0001944314,0.0001367854,0.0001112215,0.00005768954,0.0003710577,0.00001263994],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003122744,"about_ca_system_score_gemma":0.0002300462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001161753,"about_ca_topic_score_gemma":0.0005428008,"domain_scores_codex":[0.997067,0.0008682781,0.0007295089,0.0005880889,0.0003570837,0.0003899954],"domain_scores_gemma":[0.9975465,0.0009818738,0.0002691984,0.0007410404,0.0002041241,0.0002572988],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9839604,0.0001520319,0.00500629,0.0001125821,0.0004195309,0.0003688106,0.001445245,0.0000243689,0.0001318399,0.00001653772,0.00609731,0.002265],"study_design_scores_gemma":[0.987338,0.0001257669,0.007031861,0.001583715,0.000597552,0.0001420506,0.0004497328,0.0005660789,0.001345501,0.00009597302,0.0004772742,0.0002464878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840873,0.003542779,0.0000598375,0.007394753,0.000265588,0.003167047,0.0003193505,0.00006916954,0.001094182],"genre_scores_gemma":[0.9967431,0.000365543,0.0000945793,0.001736251,0.0003464464,0.0002705039,0.0001904346,0.00002574289,0.000227399],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01265581,"threshold_uncertainty_score":0.7965146,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1972791698","doi":"10.1038/nature12655","title":"Staphylococcus δ-toxin induces allergic skin disease by activating mast cells","year":2013,"lang":"en","type":"article","venue":"Nature","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":539,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"Degranulation; Superantigen; Immunology; Atopic dermatitis; Immunoglobulin E; Staphylococcus aureus; Mast cell; Pathogenesis; Antibody; Microbiology; Biology; Antigen; Toxic shock syndrome; Immune system; T cell; Receptor; Bacteria","retraction":null,"screen_n_in":null,"score":{"opus":0.005879522076625429,"gpt":0.2475599513737813,"spread":0.2416804292971559,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004119863,0.0001750065,0.0002167885,0.00007035489,0.00009235983,0.00002958453,0.0001301545,0.0006866875,0.001222164],"category_scores_gemma":[0.0001251949,0.0001371997,0.00009782175,0.0001476148,0.00007078378,0.0001534605,0.00004364279,0.001392855,0.0002645588],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002297843,"about_ca_system_score_gemma":0.00007856157,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001125647,"about_ca_topic_score_gemma":9.932011e-7,"domain_scores_codex":[0.9989949,0.00004804707,0.0001575198,0.0002717328,0.0002433372,0.0002844435],"domain_scores_gemma":[0.9991478,0.00008453497,0.00007002021,0.0002739923,0.00008134821,0.0003423419],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0001438945,0.0003663925,0.01446081,0.0001419608,0.00009793993,0.00014807,0.0001248445,0.000002310927,0.07138519,0.0000354963,0.9090969,0.003996209],"study_design_scores_gemma":[0.003535394,0.0000843649,0.5284532,0.0003401143,0.0001661264,0.00003178947,0.0006910062,0.0001407216,0.3219334,0.001133377,0.1427778,0.000712621],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860711,0.005247786,0.00000419648,0.003890688,0.0002406946,0.0003772675,0.00004446245,0.00009031384,0.004033554],"genre_scores_gemma":[0.9928745,0.00004527029,0.0001195129,0.004747612,0.0001607999,0.00004845865,0.00009577049,0.00002243677,0.00188561],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7663191,"threshold_uncertainty_score":0.9996908,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2988092601","doi":"10.1001/jamadermatol.2019.3336","title":"Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis","year":2019,"lang":"en","type":"article","venue":"JAMA Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":509,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Queen's University; Probity Medical Research; SKiN Health","funders":"Sanofi Genzyme; LEO Pharma; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Medicine; Dupilumab; Eczema Area and Severity Index; Atopic dermatitis; Randomized controlled trial; Dermatology Life Quality Index; SCORAD; Placebo; Internal medicine; Population; Quality of life (healthcare); Clinical endpoint; Pediatrics; Dermatology; Disease; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.005197194933641165,"gpt":0.231256539369391,"spread":0.2260593444357498,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005050114,0.0001766177,0.0007779573,0.0002015172,0.00003160337,0.000009504839,0.00008878336,0.0001894539,0.0000611467],"category_scores_gemma":[0.00008235284,0.0001440065,0.00004270887,0.0001812249,0.00009341128,0.0001011574,0.00005801639,0.0001981087,0.00007898429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002505869,"about_ca_system_score_gemma":0.000109676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002677649,"about_ca_topic_score_gemma":0.00006600513,"domain_scores_codex":[0.9987507,0.0001303938,0.0004028159,0.0002782658,0.0001342354,0.0003036022],"domain_scores_gemma":[0.9992836,0.00008648451,0.00009472482,0.000297726,0.00007768446,0.0001598411],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004642125,0.0002352355,0.9910677,0.00062398,0.00007945327,0.000644771,0.0003262235,0.00007727715,0.00007529683,0.0003121219,0.0008882327,0.001027596],"study_design_scores_gemma":[0.02908248,0.0001117088,0.963983,0.0008223468,0.00006674568,0.003733413,0.0000997227,0.0007120642,0.0005112378,0.0001171608,0.0005968531,0.0001632563],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920872,0.0005766826,0.00007776263,0.004341658,0.00006955727,0.0009063764,0.000007233078,0.00003182742,0.001901632],"genre_scores_gemma":[0.9964086,0.00003790802,0.0001709495,0.00322389,0.00001056707,0.0000253166,0.00001092251,0.0000167112,0.00009517402],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02708467,"threshold_uncertainty_score":0.5872415,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3044651017","doi":"10.1016/s0140-6736(20)30732-7","title":"Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":491,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Innovaderm (Canada)","funders":"LEO Pharma; Galderma; Lundbeckfonden; Glenmark Pharmaceuticals; Kiniksa Pharmaceuticals; British Skin Foundation; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Placebo; Adverse effect; Randomized controlled trial; Internal medicine; Clinical trial; Janus kinase inhibitor; Clinical endpoint; Severity of illness; Physical therapy; Pediatrics; Dermatology","retraction":null,"screen_n_in":null,"score":{"opus":0.02407745882816653,"gpt":0.2923664040459151,"spread":0.2682889452177485,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001301419,0.0001722908,0.000959789,0.00004525068,0.00005997419,0.00001737388,0.0001028088,0.0000745441,0.00002175991],"category_scores_gemma":[0.0001955453,0.0001076537,0.00004688558,0.0001145487,0.0001039374,0.00006094147,0.00004221175,0.0001989962,0.000005665299],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009509919,"about_ca_system_score_gemma":0.00005344139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001467147,"about_ca_topic_score_gemma":0.00002236484,"domain_scores_codex":[0.9988554,0.0001451009,0.0003741377,0.0002343161,0.0001509807,0.0002401328],"domain_scores_gemma":[0.9992427,0.0002008669,0.000116566,0.0002030328,0.00003840847,0.0001984418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9864388,0.0003174388,0.009517399,0.0004603861,0.0001216581,0.00007986589,0.001711892,0.00005521912,0.0000136853,0.00002057276,0.0006074948,0.0006556152],"study_design_scores_gemma":[0.9835843,0.0003058889,0.01172759,0.0008637272,0.0002119848,0.0000477681,0.0001509457,0.002674842,0.0001356852,0.00001340227,0.0001643326,0.0001195127],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900196,0.0008137956,0.00007070881,0.004340263,0.00003191003,0.004332687,0.00003292391,0.00002917583,0.0003289663],"genre_scores_gemma":[0.9970586,0.0002765626,0.00009601745,0.002219039,0.0001736531,0.000130053,0.0000163717,0.00001339374,0.00001635842],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007038982,"threshold_uncertainty_score":0.4389991,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3028230790","doi":"10.2340/00015555-3510","title":"Prevalence and Incidence of Atopic Dermatitis: A Systematic Review","year":2020,"lang":"en","type":"review","venue":"Acta Dermato Venereologica","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":488,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Epidemiology; Atopic dermatitis; Confidence interval; Pediatrics; Demography; Dermatology; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02992108687556292,"gpt":0.3161594664384518,"spread":0.2862383795628888,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001909158,0.0005175396,0.005224279,0.0001158908,0.00006497543,0.00001388729,0.0004367818,0.0003879926,0.0001442012],"category_scores_gemma":[0.002365043,0.0003485582,0.0005470145,0.0003323724,0.0002980945,0.0001020407,0.000280312,0.0004094254,0.0001003163],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003723666,"about_ca_system_score_gemma":0.0003450317,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001612248,"about_ca_topic_score_gemma":2.823874e-7,"domain_scores_codex":[0.996767,0.0006314763,0.001493587,0.0004995058,0.0003147869,0.0002936816],"domain_scores_gemma":[0.9970112,0.0008123437,0.001047453,0.000770263,0.00009248532,0.0002662421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000001774186,0.00004886589,0.0004646605,0.9868286,0.000301981,0.000757115,0.00002273721,2.507128e-9,9.647502e-8,0.00006929478,0.006798509,0.004706382],"study_design_scores_gemma":[0.0001441274,0.00003611148,0.0003345066,0.8110253,0.01058744,0.01056975,0.000006337033,0.000002914118,0.000001678981,0.0000487308,0.1669607,0.0002823634],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000323934,0.9956363,0.000004669729,0.0006816473,0.00005445826,0.002886973,0.00004482635,0.00009457964,0.0005641346],"genre_scores_gemma":[0.003537347,0.9922749,0.0001146101,0.00336503,0.00002672229,0.0004981348,0.00005537111,0.00003166514,0.00009616853],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1758032,"threshold_uncertainty_score":0.9998966,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3189956257","doi":"10.1001/jamadermatol.2021.3023","title":"Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis","year":2021,"lang":"en","type":"article","venue":"JAMA Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":485,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; SKiN Health; University of Calgary","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology","retraction":null,"screen_n_in":null,"score":{"opus":0.00699636040548147,"gpt":0.2408881941635202,"spread":0.2338918337580387,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004250415,0.0001936615,0.0007315529,0.0001666482,0.00005891567,0.00001305501,0.00008195899,0.0002369782,0.0001759607],"category_scores_gemma":[0.0002596363,0.0001722889,0.00004779082,0.0002962272,0.0001848362,0.0001136721,0.0000828351,0.0002456884,0.00002870494],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002178874,"about_ca_system_score_gemma":0.0002371695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002411104,"about_ca_topic_score_gemma":0.0001473522,"domain_scores_codex":[0.9985113,0.0001665722,0.0004737875,0.0003584667,0.0001518218,0.0003380423],"domain_scores_gemma":[0.9989367,0.0002669522,0.00009108416,0.0003404872,0.000163299,0.0002015116],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00866467,0.0006977258,0.954137,0.001755245,0.0002282044,0.0139254,0.002106306,0.00005408783,0.0000823356,0.003169183,0.009643313,0.005536511],"study_design_scores_gemma":[0.0188673,0.0001033962,0.9467006,0.0008958794,0.00008419807,0.02424151,0.00039615,0.0003920721,0.003906515,0.0002653893,0.003915295,0.0002316343],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9825703,0.001196487,0.0001379775,0.01134291,0.00005866345,0.0003890861,0.00002750963,0.00004099678,0.00423609],"genre_scores_gemma":[0.9945486,0.0002013379,0.0009800968,0.004005721,0.00001838836,0.00003442759,0.00008409417,0.0000196,0.0001077968],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01197825,"threshold_uncertainty_score":0.7025737,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4247682368","doi":"10.1016/j.jaci.2006.03.045","title":"Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report","year":2006,"lang":"en","type":"review","venue":"Journal of Allergy and Clinical Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":460,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; McGill University","funders":"","keywords":"Atopic dermatitis; Medicine; Guideline; Allergy; Asthma; Family medicine; Clinical immunology; Immunology; Task force; Pediatrics; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03873807815885866,"gpt":0.3789179661088687,"spread":0.3401798879500101,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001173475,0.0006672742,0.006187068,0.0005637049,0.00007466063,0.000009050672,0.0002662829,0.001723404,0.00002802861],"category_scores_gemma":[0.001113084,0.0005180998,0.0006306976,0.0001954705,0.007172148,0.00009493829,0.0004034297,0.001804927,0.00000105701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003581397,"about_ca_system_score_gemma":0.0002589959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00016435,"about_ca_topic_score_gemma":0.00007365205,"domain_scores_codex":[0.9901673,0.002593735,0.005823209,0.0007748569,0.0001674829,0.0004734643],"domain_scores_gemma":[0.9902619,0.003616003,0.005429451,0.0003082561,0.0001448742,0.0002394777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001805934,0.002387693,0.2725032,0.0006652554,0.026577,0.001119348,0.0001224131,1.568623e-7,0.00000549914,0.0002115037,0.0005091427,0.6940929],"study_design_scores_gemma":[0.007314978,0.003588212,0.8472059,0.00279933,0.001529207,0.02647979,0.0001149311,0.000001539747,0.000004716906,0.0001185005,0.110539,0.0003038709],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.4771302,0.5214669,5.910695e-7,0.0009152194,0.0000908033,0.0003071556,0.00003289965,0.000006407416,0.00004981041],"genre_scores_gemma":[0.09215097,0.9070951,0.000308992,0.0001820452,0.000118983,0.00001317208,0.00004459665,0.00004518281,0.0000409925],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.693789,"threshold_uncertainty_score":0.9997271,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3119334612","doi":"10.1016/j.anai.2020.12.020","title":"Atopic dermatitis in the pediatric population","year":2021,"lang":"en","type":"article","venue":"Annals of Allergy Asthma & Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":445,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Atopic dermatitis; Latin Americans; Population; Asthma; Pediatrics; Demography; Cross-sectional study; Environmental health; Dermatology; Immunology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02301631336110018,"gpt":0.293800702509994,"spread":0.2707843891488938,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001005126,0.00008869301,0.0002456777,0.0001152504,0.00004240847,0.000004508002,0.0001097826,0.0001335368,0.0002974242],"category_scores_gemma":[0.0001666701,0.00007171488,0.00009948233,0.0002609605,0.00006542742,0.00006443222,0.00003908619,0.0001592504,0.00003683896],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000004460077,"about_ca_system_score_gemma":0.00007412643,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006992207,"about_ca_topic_score_gemma":0.00006379583,"domain_scores_codex":[0.9990369,0.0002182004,0.0002987719,0.000140412,0.0001065401,0.00019915],"domain_scores_gemma":[0.9993711,0.0001086542,0.00008821042,0.0002963282,0.0001125694,0.0000231312],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003522167,0.002526177,0.8402516,0.0003205145,0.001103419,0.004338829,0.0028498,0.00007363794,0.0006498007,0.05867665,0.06649039,0.02236698],"study_design_scores_gemma":[0.000514479,0.00005357955,0.9697332,0.00001765679,0.000002797777,0.0006496318,0.0002325905,0.000007765784,0.0006857705,0.001598604,0.02644619,0.00005775251],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9670057,0.01955066,0.00001150768,0.01080143,0.0001341969,0.00007218256,0.000002723203,0.00001504229,0.002406595],"genre_scores_gemma":[0.9929714,0.003377338,0.0000601091,0.003291644,0.00005253178,0.0000112556,0.00007733827,0.000006529724,0.0001519179],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1294816,"threshold_uncertainty_score":0.3256586,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2096194006","doi":"10.1016/j.neuron.2010.02.025","title":"Loss of Inhibitory Interneurons in the Dorsal Spinal Cord and Elevated Itch in Bhlhb5 Mutant Mice","year":2010,"lang":"en","type":"article","venue":"Neuron","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":444,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences","keywords":"Inhibitory postsynaptic potential; Spinal cord; Dorsum; Neuroscience; Mutant; Psychology; Biology; Anatomy; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01278273617201384,"gpt":0.2839249838296367,"spread":0.2711422476576228,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001000488,0.00007923482,0.0001536108,0.00009097321,0.00001293182,0.000004459182,0.00008671692,0.00006396184,0.00002206073],"category_scores_gemma":[0.0001686308,0.00005747146,0.00002367102,0.0001148678,0.0001661828,0.00003695172,0.00003274589,0.000420013,0.000006047452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000003836721,"about_ca_system_score_gemma":0.00003508325,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004932407,"about_ca_topic_score_gemma":0.0001386501,"domain_scores_codex":[0.9993532,0.00007945343,0.0001863287,0.0001506915,0.00009869848,0.0001316674],"domain_scores_gemma":[0.9996547,0.00009050772,0.00004169136,0.0001634604,0.00001686206,0.00003283417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002104682,0.0004694835,0.7992488,0.0001194231,0.000006297832,0.001828255,0.000309905,4.392928e-7,0.1936551,0.0001163487,0.0007666298,0.001374574],"study_design_scores_gemma":[0.001137987,0.0002602247,0.9823997,0.00006522352,0.0000194168,0.0006121809,0.00007051502,0.00007584689,0.01404591,0.00006709545,0.001193984,0.0000519167],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997979,0.0001080137,6.162442e-7,0.001112726,0.0002132314,0.0001660896,0.000003215856,0.00001081989,0.0004062222],"genre_scores_gemma":[0.9991001,0.00002070799,0.000005031085,0.0008084805,0.00002740566,0.000006156952,0.000002876157,0.000007420309,0.0000217738],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1831509,"threshold_uncertainty_score":0.2343618,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2465799764","doi":"10.1111/bjd.14871","title":"Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Probity Medical Research; Innovaderm (Canada)","funders":"Pfizer","keywords":"Tofacitinib; Eczema Area and Severity Index; Tolerability; Medicine; Janus kinase inhibitor; Atopic dermatitis; Adverse effect; Randomized controlled trial; Clinical endpoint; Internal medicine; Pharmacodynamics; Dermatology; Pharmacokinetics; Onset of action; Rheumatoid arthritis","retraction":null,"screen_n_in":null,"score":{"opus":0.01635605518526289,"gpt":0.300221266251213,"spread":0.2838652110659501,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003001848,0.0001952311,0.00159583,0.000185615,0.0001798929,0.00003006318,0.0002038341,0.0002996481,0.0001197016],"category_scores_gemma":[0.005841583,0.000151733,0.0007932162,0.00008680388,0.000454036,0.0002187829,0.00004775155,0.0002439364,0.00001798137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003485198,"about_ca_system_score_gemma":0.0003237695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000031451,"about_ca_topic_score_gemma":0.000004772503,"domain_scores_codex":[0.9974054,0.0003920701,0.001287053,0.000211357,0.0002470758,0.0004570506],"domain_scores_gemma":[0.9964821,0.002089331,0.0005443761,0.0001720788,0.0003615455,0.0003505955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3345855,0.003706953,0.00448599,0.0004730819,0.002055131,0.03716597,0.0004534785,1.445041e-7,0.0004043368,0.003857856,0.516909,0.09590261],"study_design_scores_gemma":[0.733708,0.0003347938,0.0003941745,0.0004122136,0.0004553757,0.2005355,0.00005731506,0.00001178688,0.002538472,0.003757763,0.05772696,0.00006759215],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9713897,0.006445853,0.009666777,0.009321663,0.001010006,0.001193084,0.00006856734,0.000046867,0.0008574738],"genre_scores_gemma":[0.9947352,0.0008753837,0.001134983,0.002005843,0.0004475793,0.000121375,0.00001467951,0.00002450442,0.000640398],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.459182,"threshold_uncertainty_score":0.6993343,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108413296","doi":"10.1542/peds.110.1.e2","title":"Efficacy and Safety of Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Children","year":2002,"lang":"en","type":"article","venue":"PEDIATRICS","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"Novartis Pharma; Novartis","keywords":"Pimecrolimus; Medicine; Discontinuation; Atopic dermatitis; Dermatology; Randomized controlled trial; Calcineurin; Eczema Area and Severity Index; Regimen; Atopy; Allergy; Surgery; Immunology; Transplantation","retraction":null,"screen_n_in":null,"score":{"opus":0.009932234970390509,"gpt":0.2460432954399849,"spread":0.2361110604695944,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008741333,0.00006536055,0.0001808623,0.0001193118,0.00001386392,0.000002356907,0.00008008016,0.00004796018,0.00005498032],"category_scores_gemma":[0.00003081975,0.00004993282,0.00002849751,0.0002356159,0.00005646394,0.00002682454,0.00003355713,0.00008397272,0.000004388466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000767654,"about_ca_system_score_gemma":0.000006261516,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001450367,"about_ca_topic_score_gemma":0.000005404235,"domain_scores_codex":[0.9993765,0.00004311849,0.0002542688,0.00009268533,0.0001227748,0.0001106309],"domain_scores_gemma":[0.9996271,0.0001010861,0.00006235568,0.0001680834,0.00001234326,0.00002910065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002058259,0.0006059609,0.9947322,0.000262811,0.00001772921,0.00008947095,0.0003014937,0.000002893986,2.376737e-7,0.00009815375,0.0006001871,0.003268283],"study_design_scores_gemma":[0.002334318,0.00003890329,0.9972258,0.00004421276,0.0001188891,0.00006942989,0.00002848525,0.00001718013,0.00001003692,0.00005154014,0.00002035538,0.00004082358],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912102,0.005917171,0.000008894128,0.0002950429,0.00001990341,0.0003404306,0.000006777833,0.000005531193,0.002196101],"genre_scores_gemma":[0.9938977,0.005824055,0.00005213077,0.0001529901,0.00002430656,0.000006708394,0.00001029831,0.000004125357,0.00002770472],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00322746,"threshold_uncertainty_score":0.2036201,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2985069633","doi":"10.2340/00015555-3164","title":"European S2k Guideline on Chronic Pruritus","year":2019,"lang":"en","type":"article","venue":"Acta Dermato Venereologica","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":396,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Dermatology; Guideline; Atopic dermatitis; Disease; Population; Incidence (geometry); Chronic pain; Chronic urticaria; Intensive care medicine; Physical therapy; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0128492588777361,"gpt":0.2659467610129363,"spread":0.2530975021352002,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001701014,0.0002363387,0.000396832,0.0001022276,0.00008516401,0.00001635015,0.0002384545,0.0001341298,0.002332546],"category_scores_gemma":[0.000154884,0.0001756538,0.0001598931,0.0001325867,0.0001074658,0.00007167385,0.0001130637,0.0002685324,0.00515543],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005691431,"about_ca_system_score_gemma":0.0001063607,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002008052,"about_ca_topic_score_gemma":0.000001080159,"domain_scores_codex":[0.9983662,0.0001734971,0.0004383758,0.0003916619,0.0002159727,0.0004142399],"domain_scores_gemma":[0.9988266,0.00009653233,0.0001241742,0.0006917156,0.00006322139,0.0001977873],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004327577,0.0007176284,0.1099461,0.0002360117,0.0002014497,0.002621433,0.00007960797,0.00004815394,0.008224518,0.00104695,0.869682,0.006763441],"study_design_scores_gemma":[0.00256654,0.0004363313,0.1032698,0.0001827395,0.0001057659,0.001573596,0.00004660366,0.0002790822,0.004222654,0.0002627659,0.886705,0.0003491987],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7171606,0.001603132,0.00001507988,0.007234619,0.0003184085,0.0004138545,0.000009200827,0.0002978985,0.2729472],"genre_scores_gemma":[0.9858655,0.0001928724,0.0002064726,0.009214133,0.0002055079,0.0000127954,0.0001358745,0.00003256416,0.004134218],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.268813,"threshold_uncertainty_score":0.9985794,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3036639957","doi":"10.1016/j.jaad.2020.06.054","title":"Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":389,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"Sanofi Genzyme; Regeneron Pharmaceuticals","keywords":"Medicine; Dupilumab; Atopic dermatitis; Eczema Area and Severity Index; Placebo; Concomitant; Dermatology Life Quality Index; Regimen; Clinical endpoint; Randomized controlled trial; Internal medicine; Dermatology; Quality of life (healthcare); Adverse effect; Pathology; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.01426821348686097,"gpt":0.2961400137396398,"spread":0.2818718002527789,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018689,0.00020315,0.002542512,0.0001791807,0.00003098044,0.000006931483,0.0002677605,0.0001096125,0.00001647622],"category_scores_gemma":[0.0003349109,0.0001170571,0.0002210739,0.0003151487,0.000921393,0.00008035059,0.00007260197,0.0005373289,9.945899e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002384159,"about_ca_system_score_gemma":0.0002031251,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001762522,"about_ca_topic_score_gemma":0.000003872763,"domain_scores_codex":[0.9974938,0.0005115786,0.001244282,0.000181766,0.0003270976,0.0002414786],"domain_scores_gemma":[0.9975422,0.0006302738,0.001363577,0.0001347897,0.00006361074,0.0002655222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8640776,0.0003238169,0.1330559,0.00005012057,0.0008055584,0.0001828433,0.0004431652,0.00003057961,0.00006178644,0.0001118406,0.0003821097,0.0004746494],"study_design_scores_gemma":[0.8631471,0.001041188,0.1220283,0.0002399861,0.0008930993,0.01176393,0.0001601711,0.00005746371,0.0004305386,0.00002389069,0.00009744822,0.0001168787],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9708406,0.0004439222,0.0001042393,0.02650156,0.00003070961,0.002016436,0.000007934046,0.00000751251,0.00004703516],"genre_scores_gemma":[0.9950376,0.0001202969,0.0004391789,0.004301706,0.000055263,0.00002292911,0.000001007537,0.0000151693,0.000006823539],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02419698,"threshold_uncertainty_score":0.4773449,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3003334583","doi":"10.1111/bjd.18898","title":"Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":379,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Innovaderm (Canada)","funders":"Lundbeckfonden; Eli Lilly and Company","keywords":"Medicine; Placebo; Atopic dermatitis; Concomitant; Adverse effect; Randomized controlled trial; Internal medicine; Gastroenterology; Clinical endpoint; Erythema; Phases of clinical research; Clinical trial; Dermatology","retraction":null,"screen_n_in":null,"score":{"opus":0.01951308054702021,"gpt":0.2875085191582279,"spread":0.2679954386112077,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005041662,0.00024882,0.002230723,0.000239781,0.00007991786,0.0000825548,0.0001764323,0.0001830761,0.00002245071],"category_scores_gemma":[0.007711977,0.0002255592,0.0001685012,0.0002394702,0.0001562764,0.0002012036,0.00005962225,0.0004381859,0.00001268402],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003753797,"about_ca_system_score_gemma":0.0002043879,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008331295,"about_ca_topic_score_gemma":0.00004661,"domain_scores_codex":[0.995254,0.001833449,0.001842513,0.0003533353,0.0003321816,0.0003845624],"domain_scores_gemma":[0.9952347,0.003093987,0.0005481492,0.0001653714,0.0002782278,0.00067959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7579674,0.001066615,0.13463,0.00009956547,0.001128649,0.03108088,0.006272407,0.000116005,0.0002014919,0.00003171621,0.02873649,0.03866872],"study_design_scores_gemma":[0.7434934,0.0008877994,0.2372487,0.0008499856,0.0003799019,0.01203862,0.0003061182,0.0004340429,0.001534398,0.0004038298,0.00220671,0.0002164528],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9810693,0.001630258,0.002116863,0.01376236,0.0001401754,0.001061872,0.0001337324,0.00002391357,0.00006158566],"genre_scores_gemma":[0.986567,0.0002426738,0.001438807,0.01154653,0.00009563726,0.00002478768,0.00004086892,0.0000270979,0.00001660523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1026187,"threshold_uncertainty_score":0.9232513,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047893094","doi":"10.1172/jci65642","title":"Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":370,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Filaggrin; Aryl hydrocarbon receptor; Atopic dermatitis; Immunology; Cell biology; Cancer research; Chemistry; Biology; Transcription factor; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.05207025210957617,"gpt":0.3577454110220966,"spread":0.3056751589125205,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008179981,0.00009950151,0.0004886004,0.0001416432,0.00003271254,0.00001502994,0.00009359272,0.0002333472,0.0003709994],"category_scores_gemma":[0.002804051,0.00007727456,0.0002401086,0.0001030016,0.0002127623,0.0003896463,0.00002317736,0.0005662216,0.0001005679],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003481492,"about_ca_system_score_gemma":0.0003338464,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003976293,"about_ca_topic_score_gemma":0.00001785608,"domain_scores_codex":[0.9975301,0.0003260504,0.001549812,0.0001259773,0.0003222834,0.0001457752],"domain_scores_gemma":[0.9982206,0.0004482025,0.0005680414,0.0001522988,0.0002322504,0.0003785943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003039041,0.0001499899,0.9540595,0.00004968869,0.00006893736,0.0002072357,0.0001711155,0.00001082604,0.0001171982,0.00006924634,0.04328413,0.001781725],"study_design_scores_gemma":[0.00181897,0.0001569489,0.986923,0.0002421017,0.00007644291,0.0003264806,0.0001269044,0.0003064352,0.001482219,0.006686788,0.001778958,0.00007478512],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917278,0.0003762125,0.00002780412,0.006624872,0.000514912,0.0001782679,0.000001973229,0.00001841107,0.0005297078],"genre_scores_gemma":[0.9917765,0.0001128587,0.001260647,0.006219824,0.0004082012,0.000006423201,0.000005217882,0.000008537165,0.0002017973],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04150517,"threshold_uncertainty_score":0.4062183,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2071154269","doi":"10.2165/00128071-200304120-00003","title":"Psychiatric and Psychological Co-Morbidity in Patients with Dermatologic Disorders","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":369,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Western University","funders":"","keywords":"Medicine; Psychosocial; Psychiatry; Biopsychosocial model; Comorbidity; Psychological intervention; Quality of life (healthcare); Depression (economics)","retraction":null,"screen_n_in":null,"score":{"opus":0.06162790824897608,"gpt":0.4460504208589782,"spread":0.3844225126100022,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005180119,0.0005974253,0.00729281,0.0006552298,0.00006237114,0.00001478145,0.0003582,0.0006977433,0.00007083487],"category_scores_gemma":[0.0008521003,0.0003680803,0.0008989182,0.0007101031,0.002241323,0.00009825086,0.00004876042,0.002196612,0.00003647363],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003098538,"about_ca_system_score_gemma":0.000495328,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002488836,"about_ca_topic_score_gemma":0.000004382222,"domain_scores_codex":[0.9926926,0.002234493,0.003548796,0.0005954166,0.0003635314,0.0005651741],"domain_scores_gemma":[0.9938957,0.001872969,0.003008888,0.0004691305,0.0001596988,0.0005936144],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006186564,0.001899221,0.6192274,0.001105417,0.0003233218,0.0008745379,0.000005493874,6.985718e-8,2.71867e-10,0.000031427,0.004498783,0.3714157],"study_design_scores_gemma":[0.005835903,0.002689503,0.2884162,0.001693725,0.001978591,0.01896113,0.00003190927,6.776457e-7,1.248822e-8,0.0001881225,0.6797435,0.0004606725],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.09237392,0.9045616,0.00003125608,0.0007375017,0.0005602574,0.0006816555,0.00001671189,0.0000223819,0.001014692],"genre_scores_gemma":[0.05606003,0.9412664,0.0009739338,0.001533339,0.00006410536,0.00001569444,0.00003150201,0.00004729374,0.000007715377],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6752447,"threshold_uncertainty_score":0.9998771,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2991540591","doi":"10.1016/j.jaci.2019.11.025","title":"Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial","year":2019,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":357,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"AbbVie","keywords":"Medicine; Placebo; Randomized controlled trial; Atopic dermatitis; Eczema Area and Severity Index; Adverse effect; Clinical endpoint; Internal medicine; Surgery; Dermatology","retraction":null,"screen_n_in":null,"score":{"opus":0.01379008931329156,"gpt":0.2865810797549208,"spread":0.2727909904416292,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009075955,0.0001960163,0.002171915,0.000162476,0.00003812038,0.00001684906,0.0001415848,0.0003461642,0.0002812372],"category_scores_gemma":[0.001917811,0.0001253048,0.0003469753,0.00008498949,0.0002268407,0.0001264055,0.00004811853,0.0007007576,0.00004693927],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002488432,"about_ca_system_score_gemma":0.0002722181,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005379156,"about_ca_topic_score_gemma":0.000162962,"domain_scores_codex":[0.996527,0.0008635442,0.001906968,0.0002678644,0.0001794268,0.0002552201],"domain_scores_gemma":[0.9953529,0.003357978,0.0006795113,0.0002349065,0.0001875278,0.0001871723],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9913045,0.0008131216,0.001631614,0.00001031147,0.003085516,0.0005379903,0.0003093273,0.00003192971,0.000002219243,0.00008372018,0.001010708,0.00117901],"study_design_scores_gemma":[0.9733443,0.002691302,0.02014236,0.0006059738,0.0002679254,0.0005825742,0.0003381065,0.0002116328,0.000009384571,0.0007766847,0.0008882518,0.0001414539],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895116,0.001887515,0.00006793462,0.004538927,0.0006561404,0.001215146,0.000008695404,0.00001068513,0.002103341],"genre_scores_gemma":[0.9946197,0.00204138,0.0003712108,0.002049237,0.0001933503,0.00002853869,0.00001469891,0.00001266165,0.0006692036],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01851075,"threshold_uncertainty_score":0.5109781,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2161684908","doi":"10.1684/ecn.2011.0288","title":"IL-37: a new anti-inflammatory cytokine of the IL-1 family","year":2011,"lang":"en","type":"review","venue":"European Cytokine Network","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":356,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"National Research Council Canada","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Inflammation; Receptor; Cytokine; Receptor antagonist; Biology; Immunology; Interleukin 1 receptor, type II; Agonist; Interleukin; Cell biology; Antagonist; Interleukin 5; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.03970733791333941,"gpt":0.276419796744768,"spread":0.2367124588314286,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006693489,0.00087745,0.002933678,0.0001408528,0.0001722132,0.00002199345,0.001085677,0.0003218413,0.0003100829],"category_scores_gemma":[0.0002215083,0.0005614688,0.001529817,0.0007746705,0.0003984684,0.00006661072,0.0006169344,0.001081504,0.001006571],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005257188,"about_ca_system_score_gemma":0.0007741387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008267251,"about_ca_topic_score_gemma":0.000002673616,"domain_scores_codex":[0.9953456,0.001251991,0.001515965,0.0007343406,0.0004056201,0.0007465027],"domain_scores_gemma":[0.9961741,0.0002287138,0.001075286,0.001978801,0.00012381,0.0004193127],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009198124,0.0001881682,0.001379127,0.008039803,0.0009776127,0.001066956,0.00005805007,0.000006918674,0.000003459814,0.000373084,0.6683173,0.3194976],"study_design_scores_gemma":[0.0007932599,0.0000727589,0.00775052,0.017927,0.003259741,0.0006778374,0.000004554337,0.000001382236,0.000003621017,0.00004598997,0.9689954,0.0004679508],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001242858,0.9247214,0.00002784996,0.00005699632,0.001425356,0.001179262,0.0001708557,0.0001905386,0.07210352],"genre_scores_gemma":[0.0004530731,0.9899265,0.0002152151,0.0007488719,0.003107872,0.00001620093,0.0001804497,0.000287511,0.00506431],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3190296,"threshold_uncertainty_score":0.9997712,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1999690368","doi":"10.1038/ng.1017","title":"Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis","year":2011,"lang":"en","type":"review","venue":"Nature Genetics","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Institute on Alcohol Abuse and Alcoholism; National Institute on Drug Abuse; Lundbeckfonden; Wellcome Trust","keywords":"Biology; Atopic dermatitis; Genome-wide association study; Genetics; Genetic association; Computational biology; Single-nucleotide polymorphism; Gene; Immunology; Genotype","retraction":null,"screen_n_in":null,"score":{"opus":0.1040308168434679,"gpt":0.370613777962454,"spread":0.2665829611189861,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003206125,0.0003982337,0.004946897,0.0004564625,0.00008854282,0.00001410771,0.0002537084,0.001183794,0.0001900985],"category_scores_gemma":[0.001974776,0.0002881694,0.004066999,0.0005819771,0.00006519928,0.0000281682,0.00008219124,0.0005800032,0.00001746896],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001225933,"about_ca_system_score_gemma":0.0002787258,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008508103,"about_ca_topic_score_gemma":0.0002411448,"domain_scores_codex":[0.9979386,0.0001663046,0.0009233291,0.0003846386,0.000329335,0.000257744],"domain_scores_gemma":[0.9958734,0.001487119,0.001364747,0.0006217803,0.0005455624,0.0001073737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00000557643,0.00007376786,0.01460374,0.0136192,0.834021,0.00001365788,0.0001943982,0.000003978486,1.308456e-8,0.00002488164,0.09930768,0.03813209],"study_design_scores_gemma":[0.0001200585,0.000014003,0.005871441,0.00009657694,0.5145324,0.000002942428,0.00001150166,0.000001521947,0.000002097654,0.0006776243,0.478546,0.0001237953],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007296725,0.9973352,0.0002749459,0.0001658324,0.0003056246,0.0009946739,0.0007038664,0.00002774271,0.0001191512],"genre_scores_gemma":[0.0002042369,0.9944736,0.001331998,0.0004716703,0.0001544605,0.0001072641,0.0007637472,0.00003759534,0.002455387],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3792383,"threshold_uncertainty_score":0.999957,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1984525156","doi":"10.2310/6620.2007.06034","title":"A Population-Based Survey of Eczema Prevalence in the United States","year":2007,"lang":"en","type":"article","venue":"Dermatitis","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":347,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false},"ca_institutions":"","funders":"","keywords":"Medicine; Itching; Hay fever; Rash; Population; Atopic dermatitis; Asthma; Dermatology; Prevalence; Pediatrics; Demography; Environmental health; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02261216328118509,"gpt":0.2998736883587501,"spread":0.277261525077565,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004436494,0.00005849619,0.0001366847,0.0001536533,0.00002573059,0.000004326187,0.00007623473,0.00004209444,0.00008789371],"category_scores_gemma":[0.0003649963,0.00004205053,0.00002625312,0.0003996891,0.00005094965,0.00003354023,0.000005715717,0.0000683348,0.000009696012],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000110753,"about_ca_system_score_gemma":0.00003350176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002514175,"about_ca_topic_score_gemma":0.001052244,"domain_scores_codex":[0.9992462,0.0001623248,0.0002479743,0.00007018553,0.0001527097,0.0001205919],"domain_scores_gemma":[0.9989153,0.0007298326,0.00006398428,0.0001783194,0.00007931239,0.00003331291],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002138493,0.00009712616,0.9928415,0.00020408,0.000007100336,0.00008153135,0.0002435291,0.00005829567,0.000001576572,0.00003686207,0.006236058,0.0001708881],"study_design_scores_gemma":[0.0004862629,0.00001626424,0.9973125,0.0001080585,0.00001780898,0.00003727505,0.00006371145,0.001213744,0.0001878556,0.00009166564,0.0004232415,0.00004154874],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976656,0.0002245795,0.0003050175,0.001039095,0.00002964874,0.0001847424,0.00004849073,0.00001530311,0.0004874553],"genre_scores_gemma":[0.9946696,0.00002912812,0.00009203667,0.004563432,0.000005439334,0.000005612273,0.0006078936,0.000004449876,0.0000224516],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005812817,"threshold_uncertainty_score":0.3800697,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2738994169","doi":"10.1186/s40413-017-0160-5","title":"The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming","year":2017,"lang":"en","type":"review","venue":"World Allergy Organization Journal","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":338,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Microbiome; Dysbiosis; Immune system; Atopic dermatitis; Medicine; Biodiversity; Immunology; Psoriasis; Biology; Ecology; Bioinformatics","retraction":null,"screen_n_in":null,"score":{"opus":0.02189377670519158,"gpt":0.3173499630106213,"spread":0.2954561863054297,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004220725,0.000399154,0.001341179,0.0003760426,0.000670792,0.0001338908,0.0004052743,0.0003034984,0.0002328805],"category_scores_gemma":[0.0003741346,0.0002368943,0.000404194,0.0002261411,0.0003387781,0.00008838301,0.0001477553,0.001015202,0.00003413627],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002662393,"about_ca_system_score_gemma":0.0005885516,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003240015,"about_ca_topic_score_gemma":0.00001014628,"domain_scores_codex":[0.9978981,0.0003582444,0.0009267188,0.0002749866,0.00021897,0.0003229831],"domain_scores_gemma":[0.9976259,0.0001767771,0.001354915,0.000493494,0.0001225331,0.0002263895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001155227,0.0004640395,0.006036034,0.003002428,0.004868081,0.0002668208,0.0002637427,0.000009174464,0.00006096353,0.00009116127,0.005978698,0.9788433],"study_design_scores_gemma":[0.001607181,0.0002150476,0.01786016,0.01663953,0.001451528,0.01662544,0.00004877033,0.00001091737,0.00002717317,0.00009317022,0.9449369,0.0004841377],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009195618,0.9977504,0.00006901844,0.0001304189,0.0003756795,0.0005885814,0.00002149553,0.00001569915,0.0001291165],"genre_scores_gemma":[0.05247996,0.9444629,0.00005315633,0.00002420337,0.000189454,0.00001154495,0.0001263904,0.00007875619,0.002573643],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9783592,"threshold_uncertainty_score":0.9660268,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2789024274","doi":"10.1016/j.jaad.2017.12.022","title":"Dupilumab: A review of its use in the treatment of atopic dermatitis","year":2018,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":330,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SKiN Health; Probity Medical Research; University of British Columbia; Queen's University","funders":"LEO Pharma; Sanofi","keywords":"Dupilumab; Medicine; Atopic dermatitis; Eczema Area and Severity Index; Dermatology Life Quality Index; Adverse effect; Dermatology; Concomitant; Clinical trial; SCORAD; Quality of life (healthcare); Internal medicine; Placebo; Immune dysregulation; Immunology; Immune system; Pathology; Psoriasis","retraction":null,"screen_n_in":null,"score":{"opus":0.06353531610637934,"gpt":0.3890980903434734,"spread":0.3255627742370941,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002680517,0.000351972,0.005191674,0.0003779384,0.00003119751,0.000003017835,0.0008366401,0.0002388984,0.00004468657],"category_scores_gemma":[0.0006220054,0.000170671,0.001593996,0.0007171859,0.001235816,0.00008667237,0.00006397937,0.0005566452,0.000007655203],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007165332,"about_ca_system_score_gemma":0.0004697059,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001205269,"about_ca_topic_score_gemma":0.000001792071,"domain_scores_codex":[0.9949513,0.001581945,0.002612342,0.0001692759,0.0004191278,0.0002660052],"domain_scores_gemma":[0.9916438,0.001115688,0.006555532,0.00042141,0.0001734244,0.00009009662],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003152503,0.003797783,0.03565189,0.4123263,0.006217588,0.001404301,0.0009273596,5.708137e-7,0.00000650679,0.0005770436,0.1725542,0.3662212],"study_design_scores_gemma":[0.0007346845,0.0002944697,0.007693443,0.08100236,0.004353898,0.03175022,0.00003782765,8.889775e-7,0.00006185344,0.00004749882,0.8739003,0.0001225483],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008594937,0.9849892,0.00000135603,0.005363,0.0001129329,0.0007941264,0.00004454052,0.000002981307,0.00009690279],"genre_scores_gemma":[0.007695912,0.9896696,0.0001216553,0.002366011,0.00007024792,0.00002122846,0.00000431435,0.00002289343,0.00002818417],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7013461,"threshold_uncertainty_score":0.6959763,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2783829013","doi":"10.1016/j.jaad.2018.01.017","title":"Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Sanofi Genzyme; LEO Pharma; Dermira; Vanda Pharmaceuticals; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Roivant Sciences; Celgene; Genentech; Valeant Pharmaceuticals International; Sanofi; GlaxoSmithKline; Pfizer; King's College London; Galderma; Eli Lilly and Company","keywords":"Medicine; Eczema Area and Severity Index; Placebo; Atopic dermatitis; Adverse effect; Randomized controlled trial; Clinical endpoint; Internal medicine; Placebo-controlled study; Gastroenterology; Dermatology; Double blind; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.009610947437418426,"gpt":0.3044593541179478,"spread":0.2948484066805294,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004380601,0.0003450194,0.004448553,0.0003712623,0.0001308556,0.00001260032,0.0003853189,0.0002094563,0.00003646483],"category_scores_gemma":[0.001010723,0.000207744,0.0003873091,0.0003231059,0.001884926,0.0002016883,0.0001082659,0.0006278662,0.000001543589],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000403624,"about_ca_system_score_gemma":0.0002874791,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003990945,"about_ca_topic_score_gemma":0.000009611429,"domain_scores_codex":[0.9952517,0.001358387,0.002223842,0.0002938681,0.0004451224,0.0004270539],"domain_scores_gemma":[0.9957065,0.001208156,0.002327282,0.0002275036,0.0002041296,0.0003264521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9852263,0.001537449,0.00773649,0.00008914383,0.0009741254,0.0001515257,0.0007051021,0.00002242774,0.0009044553,0.00007811008,0.0008359529,0.001738957],"study_design_scores_gemma":[0.9683586,0.003447291,0.01477239,0.0005320233,0.0009126646,0.006688473,0.0002069618,0.002177981,0.002415798,0.0001557835,0.0001222203,0.0002098332],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835728,0.0007798948,0.0003737892,0.01251653,0.000113278,0.002511553,0.00002610036,0.00001136766,0.00009462149],"genre_scores_gemma":[0.9968925,0.0003620359,0.0004017283,0.002155524,0.00009739819,0.00003869064,0.000005327362,0.00002306369,0.00002378278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01686768,"threshold_uncertainty_score":0.8471555,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3124513630","doi":"10.1016/j.jaci.2021.01.013","title":"Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council","year":2021,"lang":"en","type":"review","venue":"Journal of Allergy and Clinical Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":326,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Innovaderm (Canada)","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; Glenmark Pharmaceuticals; Lundbeckfonden; Dermira; Regeneron Pharmaceuticals; Celgene; AbbVie; Sanofi; MedImmune; GlaxoSmithKline; Rockefeller University; School of Public Health, University of California Berkeley; Pfizer; Galderma; Eli Lilly and Company","keywords":"Atopic dermatitis; Medicine; Dermatology; Family medicine; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.09047436045665698,"gpt":0.3909362688269438,"spread":0.3004619083702869,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000872543,0.0001819442,0.002203583,0.00009084786,0.00002344699,0.000004905478,0.0003427095,0.0004497035,0.0003105117],"category_scores_gemma":[0.002584621,0.0001058867,0.0009889321,0.0001413751,0.0003552185,0.00003534382,0.0001275623,0.0009499824,0.000006806912],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009427353,"about_ca_system_score_gemma":0.001538273,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003767091,"about_ca_topic_score_gemma":0.00002452412,"domain_scores_codex":[0.9967391,0.0006418305,0.002032927,0.0001636016,0.0002964678,0.0001260213],"domain_scores_gemma":[0.9970224,0.0009449429,0.001339487,0.0002885787,0.000343548,0.00006097405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001453368,0.001320824,0.002537848,0.008846628,0.01703966,0.001525768,0.000023249,1.032852e-7,2.310927e-7,0.0005564622,0.05704113,0.9109628],"study_design_scores_gemma":[0.0009313791,0.0001591509,0.008979557,0.07982238,0.001035887,0.003188055,0.00001368023,3.184024e-7,3.80341e-7,0.00005709171,0.9057381,0.00007404532],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000535236,0.9935669,6.256196e-7,0.003129998,0.001388779,0.0001620289,0.000006359791,0.000001983176,0.001208144],"genre_scores_gemma":[0.0001641058,0.997454,0.00002618993,0.002069333,0.00009225629,0.000004529876,0.000009892714,0.00001015934,0.0001695222],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9108887,"threshold_uncertainty_score":0.4317936,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W76367842","doi":"10.1016/j.jaad.2014.08.038","title":"Guidelines of care for the management of atopic dermatitis","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"Chugai Pharmaceutical; National Institutes of Health; Astellas Pharma; LEO Pharma; Galderma; Dermira; Regeneron Pharmaceuticals; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Celgene; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Atopic dermatitis; Dermatology; MEDLINE","retraction":null,"screen_n_in":null,"score":{"opus":0.02141403959256145,"gpt":0.3423750589506289,"spread":0.3209610193580674,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001493889,0.0001082869,0.0008125282,0.0001037991,0.0000501781,0.000001363856,0.0004711319,0.00006428734,0.00001102875],"category_scores_gemma":[0.0001807703,0.00005891167,0.0003859496,0.0001709547,0.0007742774,0.00003647463,0.00008330278,0.0001816063,7.783046e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001110453,"about_ca_system_score_gemma":0.00004837269,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005485256,"about_ca_topic_score_gemma":7.088275e-7,"domain_scores_codex":[0.9984379,0.0001364067,0.0009636926,0.00007610086,0.000232132,0.0001537675],"domain_scores_gemma":[0.9973001,0.0003967572,0.001797724,0.0001977962,0.000254985,0.00005259131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001573817,0.0004975954,0.6474422,0.008928242,0.005717746,0.00007290005,0.001742128,0.0003567903,0.002226319,0.01527838,0.2198964,0.09626756],"study_design_scores_gemma":[0.004423513,0.0003752035,0.8020032,0.001332992,0.003265696,0.007950579,0.004399115,0.0005300123,0.04841658,0.003899174,0.123209,0.000194959],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9133167,0.009071535,0.001768423,0.07455054,0.0002475875,0.0004173539,0.00001883509,0.000006391135,0.0006026078],"genre_scores_gemma":[0.9926705,0.0009936785,0.003360661,0.002870355,0.00005375445,0.000005439091,6.669485e-7,0.000009773768,0.00003522123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.154561,"threshold_uncertainty_score":0.2852857,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4389886423","doi":"10.1016/j.anai.2023.11.009","title":"Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations","year":2023,"lang":"en","type":"article","venue":"Annals of Allergy Asthma & Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Queen's University; McMaster University; University of Saskatchewan; St. Joseph’s Healthcare Hamilton; Impact","funders":"Canadian Institutes of Health Research; McMaster University","keywords":"Medicine; Asthma; Atopic dermatitis; Task force; Allergy; Immunology; Clinical immunology; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05626347791804799,"gpt":0.3545232837529525,"spread":0.2982598058349045,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0007400623,0.0006219166,0.002319832,0.00127929,0.000195535,0.000006470214,0.0004158481,0.0004867156,0.0001013085],"category_scores_gemma":[0.002228157,0.0005932158,0.0002497064,0.001171869,0.008217744,0.000324856,0.0004126265,0.000693986,0.000008162481],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003085369,"about_ca_system_score_gemma":0.0002922343,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001449745,"about_ca_topic_score_gemma":0.0002553714,"domain_scores_codex":[0.9949553,0.0008501629,0.002223501,0.0008122563,0.0003828992,0.000775887],"domain_scores_gemma":[0.9947042,0.001355095,0.002266382,0.0007242757,0.000740257,0.0002098215],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02619258,0.008437934,0.004150725,0.002720791,0.08755495,0.001674891,0.01035799,0.001363466,0.1625374,0.1705105,0.3301625,0.1943363],"study_design_scores_gemma":[0.01017332,0.009059254,0.4111421,0.001528239,0.00008725927,0.001639981,0.01238021,0.0007398017,0.01651482,0.002330283,0.533497,0.0009077581],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8526702,0.01646617,0.0001715669,0.1287237,0.0003661278,0.0006543506,0.0003569093,0.0000953276,0.0004956478],"genre_scores_gemma":[0.9250383,0.06557843,0.003496561,0.005070365,0.00005002785,0.0001021122,0.0003522409,0.00007251569,0.0002394305],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4069913,"threshold_uncertainty_score":0.9996519,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3090227268","doi":"10.1111/bjd.19573","title":"Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"LEO Pharma","keywords":"Medicine; Placebo; Atopic dermatitis; Double blind; Dermatology; Randomized controlled trial; Internal medicine; Alternative medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03726144453849478,"gpt":0.3107739583228424,"spread":0.2735125137843477,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002208467,0.000268959,0.002376144,0.00006115766,0.0002178874,0.00007011274,0.0003271691,0.0002115704,0.00008321685],"category_scores_gemma":[0.001338945,0.0001658134,0.0009220587,0.0001154962,0.0002990242,0.00011615,0.00002830092,0.0002872131,0.000007166065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005583829,"about_ca_system_score_gemma":0.0003679814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009444317,"about_ca_topic_score_gemma":0.00009475412,"domain_scores_codex":[0.9964036,0.0005922684,0.002054879,0.0002706264,0.0003075966,0.0003709668],"domain_scores_gemma":[0.9937769,0.00445471,0.0008298167,0.0002759633,0.000318011,0.0003445923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9714919,0.0009771221,0.00009350967,0.00003781326,0.002037528,0.002200966,0.002371782,0.0001032711,0.00001394564,0.00004816433,0.01375654,0.0068675],"study_design_scores_gemma":[0.9751604,0.0007375014,0.0002281549,0.000176168,0.002677931,0.01064435,0.0006067785,0.005090913,0.0006202883,0.0001346571,0.00377585,0.000146997],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9266635,0.01427589,0.004372388,0.04685624,0.0007056376,0.006742788,0.0002107522,0.00002500717,0.0001478019],"genre_scores_gemma":[0.9931586,0.002000019,0.0003847196,0.003550622,0.0004526373,0.0002953097,0.00005606428,0.00002263402,0.00007934107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06649516,"threshold_uncertainty_score":0.6761674,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122580582","doi":"10.1111/vde.12118","title":"Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (<scp>A</scp>ntimicrobial<scp>G</scp>uidelines<scp>W</scp>orking<scp>G</scp>roup of the<scp>I</scp>nternational<scp>S</scp>ociety for<scp>C</scp>ompanion<scp>A</scp>nimal<scp>I</scp>nfectious<scp>D</scp>iseases)","year":2014,"lang":"en","type":"review","venue":"Veterinary Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":309,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan; University of Guelph","funders":"","keywords":"Antimicrobial; Medicine; Folliculitis; Microbiology; Dermatology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.0701591606187095,"gpt":0.3435551486480619,"spread":0.2733959880293524,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","sts","scholarly_communication","open_science","research_integrity"],"consensus_categories":["metaepi_narrow","metaepi_broad","sts","research_integrity"],"category_scores_codex":[0.006359471,0.01234188,0.02194426,0.005488915,0.005489381,0.002083015,0.01128935,0.01099017,0.00009245444],"category_scores_gemma":[0.09741827,0.01099908,0.01313839,0.006462216,0.007619842,0.003125646,0.005913802,0.007553782,0.000734289],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00186736,"about_ca_system_score_gemma":0.006858619,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001338934,"about_ca_topic_score_gemma":0.000677605,"domain_scores_codex":[0.9468314,0.007218932,0.01722404,0.01097136,0.005719301,0.01203494],"domain_scores_gemma":[0.8631411,0.1019863,0.0140374,0.008658376,0.007770346,0.004406577],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001588284,0.006649943,0.01622012,0.02243629,0.01350778,0.00267703,0.006441452,0.0004190112,0.009771826,0.001193599,0.9158744,0.004649793],"study_design_scores_gemma":[0.01949404,0.00367477,0.005115504,0.009590317,0.01215585,0.02463262,0.008010847,0.001408713,0.01093645,0.0007412099,0.9034367,0.0008030144],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.6423246,0.2952339,0.001883351,0.0008184275,0.01766094,0.01901192,0.01708892,0.002220076,0.0037578],"genre_scores_gemma":[0.1474898,0.7548481,0.005489395,0.01375241,0.02088466,0.0139919,0.02186261,0.005660857,0.01602034],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.4948349,"threshold_uncertainty_score":0.9989529,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131462541","doi":"10.1067/mai.2003.1414","title":"Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions","year":2003,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":307,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Christie (Canada)","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Fibrosis; Medicine; Immunohistochemistry; Van Gieson's stain; Pathology; Inflammation; Interleukin; Hyperplasia; Skin biopsy; Biopsy; Cytokine; H&E stain; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.02352157449735499,"gpt":0.3349297775712565,"spread":0.3114082030739015,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041956,0.0001149422,0.0007313066,0.000134559,0.00005453991,0.000004803641,0.00006705506,0.0003577826,0.0001125204],"category_scores_gemma":[0.0004407588,0.0000847182,0.0001079732,0.00006376299,0.0005374773,0.00008814319,0.0000613524,0.0004777207,6.414504e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001059915,"about_ca_system_score_gemma":0.0001484821,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007050979,"about_ca_topic_score_gemma":0.00002778389,"domain_scores_codex":[0.9984298,0.0003216565,0.0008447511,0.0001495524,0.00008066829,0.0001735814],"domain_scores_gemma":[0.9986646,0.0006541883,0.0003438674,0.0001305673,0.00006875048,0.0001379813],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00428239,0.001470965,0.9137841,0.000086967,0.00337662,0.0009680689,0.000331753,8.48168e-7,0.06150974,0.001340883,0.003567831,0.00927977],"study_design_scores_gemma":[0.0106997,0.001615078,0.9591485,0.0003679107,0.0003721442,0.001409216,0.0001984548,0.000005863559,0.007044795,0.001525421,0.01748412,0.0001288628],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989403,0.009139167,0.00005194392,0.001011999,0.0001273174,0.00006735958,0.000007129799,0.000003475581,0.0001885897],"genre_scores_gemma":[0.9841045,0.01516134,0.0003658981,0.0001590031,0.0000549068,9.017831e-7,0.000001752599,0.000007204601,0.0001444685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05446495,"threshold_uncertainty_score":0.3454708,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2276335262","doi":"10.1016/j.jaad.2015.10.043","title":"Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":305,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Galderma; Astellas Pharma; Regeneron Pharmaceuticals; Genentech; Celgene; Valeant Pharmaceuticals International; Sanofi; Chugai Pharmaceutical; Pfizer; Amgen","keywords":"Medicine; Dupilumab; Atopic dermatitis; Quality of life (healthcare); Dermatology Life Quality Index; Anxiety; Eczema Area and Severity Index; Depression (economics); Severity of illness; Clinical trial; Generalizability theory; SCORAD; Disease; Internal medicine; Dermatology; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.02186583079233416,"gpt":0.3439859349347897,"spread":0.3221201041424555,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001197859,0.0001795157,0.001701899,0.0002973815,0.0000258226,0.000001782729,0.0003918024,0.0001885488,0.00004046506],"category_scores_gemma":[0.0008133829,0.0001038029,0.0004220741,0.0002860885,0.0008309296,0.00011198,0.0001286587,0.0004102811,0.000005121228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003476518,"about_ca_system_score_gemma":0.0002411912,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004724002,"about_ca_topic_score_gemma":0.000005350932,"domain_scores_codex":[0.996236,0.0007239476,0.002254339,0.0001878393,0.000371813,0.0002260396],"domain_scores_gemma":[0.9959501,0.0008200378,0.002619967,0.0002518724,0.0001518125,0.0002062348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4251744,0.009716589,0.3200656,0.0008204366,0.00342385,0.001744377,0.009551568,0.0001279307,0.0135761,0.0004341851,0.04676425,0.1686007],"study_design_scores_gemma":[0.3767871,0.006929406,0.5045292,0.006914364,0.001367607,0.008866151,0.002219104,0.0005665753,0.07377686,0.0085753,0.008732768,0.0007355859],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9767566,0.0006997944,0.00007067336,0.02173896,0.0002255152,0.0003849536,0.00005130515,0.000004790078,0.0000673547],"genre_scores_gemma":[0.9971086,0.000559444,0.0005495117,0.001675686,0.00007589868,0.000006285187,0.000001258512,0.00001383114,0.000009527637],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1844636,"threshold_uncertainty_score":0.4232959,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3120299325","doi":"10.1038/s41586-020-03118-2","title":"Local immune response to food antigens drives meal-induced abdominal pain","year":2021,"lang":"en","type":"article","venue":"Nature","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":300,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"National Institute of Allergy and Infectious Diseases; Genentech; National Institutes of Health; Wellcome Trust; Crohn's and Colitis Canada; KU Leuven; Fonds Wetenschappelijk Onderzoek","keywords":"Irritable bowel syndrome; Medicine; Sensitization; Immune system; Histamine; Abdominal pain; Immunology; Antigen; Ingestion; Immunoglobulin E; Food allergy; Mast cell; Gastroenterology; Internal medicine; Antibody; Allergy","retraction":null,"screen_n_in":null,"score":{"opus":0.01038062018870963,"gpt":0.2830931745629607,"spread":0.2727125543742511,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003575789,0.000132117,0.0002842468,0.00008903828,0.00008507449,0.00001157391,0.00008999171,0.000830363,0.0002249613],"category_scores_gemma":[0.001800713,0.0001150387,0.0001311539,0.0002688866,0.00005046887,0.00003335504,0.00005220068,0.001124654,0.00008639134],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003103131,"about_ca_system_score_gemma":0.00028969,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001239157,"about_ca_topic_score_gemma":0.00001055364,"domain_scores_codex":[0.9987568,0.0003451894,0.0001654837,0.0002639908,0.0002194868,0.0002490073],"domain_scores_gemma":[0.998966,0.0002842842,0.00002904477,0.0003602633,0.0001574162,0.0002030063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.02581126,0.001201872,0.01782557,0.0003140209,0.0007408361,0.01612851,0.002088056,0.000007423448,0.6147251,0.0006608536,0.288018,0.03247857],"study_design_scores_gemma":[0.00291676,0.0006123212,0.6217638,0.0003241632,0.0001788661,0.001331966,0.001592314,0.00007693826,0.2791432,0.0002726986,0.09144959,0.0003373441],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9734026,0.005785876,0.0003466868,0.01898084,0.0003087926,0.0001668975,0.00001670709,0.00006676722,0.0009248097],"genre_scores_gemma":[0.9890114,0.00001444482,0.0006477289,0.009199838,0.00009032632,0.000009620981,0.00003204857,0.0000163637,0.0009782142],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6039382,"threshold_uncertainty_score":0.640452,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3159897478","doi":"10.1016/j.jaad.2021.04.085","title":"Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":297,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"Incyte; Intel Corporation","keywords":"Medicine; Atopic dermatitis; Ruxolitinib; Eczema Area and Severity Index; Clinical endpoint; Randomized controlled trial; Dermatology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0536459511798173,"gpt":0.3889586485293915,"spread":0.3353126973495743,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002306083,0.0001767427,0.002113462,0.0001014657,0.00008313942,0.000002859795,0.0001944164,0.00009172074,0.00001059436],"category_scores_gemma":[0.001000201,0.00009134899,0.0005335539,0.0001794697,0.002119066,0.00005095113,0.00005490996,0.0001895864,3.540448e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002349726,"about_ca_system_score_gemma":0.0001730888,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001979569,"about_ca_topic_score_gemma":0.000002093836,"domain_scores_codex":[0.997485,0.0004474295,0.001522139,0.0001473827,0.0002122935,0.0001857742],"domain_scores_gemma":[0.991104,0.005930612,0.002409218,0.0002235934,0.0002423827,0.0000901674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9303795,0.004606132,0.01216865,0.0005513922,0.01607828,0.0002338271,0.006125495,0.00004850192,0.001462454,0.001637813,0.01154715,0.01516077],"study_design_scores_gemma":[0.8532061,0.0006925902,0.02615532,0.0006212122,0.006455794,0.006115458,0.003480459,0.0001030393,0.08726152,0.001827098,0.01392496,0.0001564373],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9284139,0.03388197,0.00009260741,0.0366115,0.0001294867,0.0006367108,0.0001532038,0.000003855471,0.00007675251],"genre_scores_gemma":[0.9779113,0.02036793,0.000734903,0.0008320821,0.00008131649,0.00001667085,0.000007843514,0.00001053375,0.00003743853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08579907,"threshold_uncertainty_score":0.7807788,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}